mesalamine has been researched along with Jaundice in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Jaundice: A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ikeda, M | 1 |
Najima, M | 1 |
Morizane, C | 1 |
Ueno, H | 1 |
Okusaka, T | 1 |
Nayar, M | 1 |
Cunliffe, W | 1 |
Cross, P | 1 |
Oppong, K | 1 |
1 review available for mesalamine and Jaundice
Article | Year |
---|---|
[Palliative therapy in patients with biliary tract cancer].
Topics: Abdominal Pain; Analgesics; Antineoplastic Agents; Back Pain; Biliary Tract Neoplasms; Drainage; Fee | 2006 |
1 other study available for mesalamine and Jaundice
Article | Year |
---|---|
Mesalazine-induced jaundice, eosonophilia, and thrombocytopenia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Eosinophilia; Humans; Jaundice; Male; | 2008 |